PMID- 19183347 OWN - NLM STAT- MEDLINE DCOM- 20090318 LR - 20221207 IS - 1469-1809 (Electronic) IS - 0003-4800 (Print) IS - 0003-4800 (Linking) VI - 73 IP - 2 DP - 2009 Mar TI - Variants in intron 13 of the ELMO1 gene are associated with diabetic nephropathy in African Americans. PG - 152-9 LID - 10.1111/j.1469-1809.2008.00498.x [doi] AB - Variants in the engulfment and cell motility 1 (ELMO1) gene are associated with nephropathy due to type 2 diabetes mellitus (T2DM) in a Japanese cohort. We comprehensively evaluated this gene in African American (AA) T2DM patients with end-stage renal disease (ESRD). Three hundred and nine HapMap tagging SNPs and 9 reportedly associated SNPs were genotyped in 577 AA T2DM-ESRD patients and 596 AA non-diabetic controls, plus 43 non-diabetic European American controls and 45 Yoruba Nigerian samples for admixture adjustment. Replication analyses were conducted in 558 AA with T2DM-ESRD and 564 controls without diabetes. Extension analyses included 328 AA with T2DM lacking nephropathy and 326 with non-diabetic ESRD. The original and replication analyses confirmed association with four SNPs in intron 13 (permutation p-values for combined analyses = 0.001-0.003), one in intron 1 (P = 0.004) and one in intron 5 (P = 0.002) with T2DM-associated ESRD. In a subsequent combined analysis of all 1,135 T2DM-ESRD cases and 1,160 controls, an additional 7 intron 13 SNPs produced evidence of association (P = 3.5 x 10(-5)- P = 0.05). No associations were seen with these SNPs in those with T2DM lacking nephropathy or with ESRD due to non-diabetic causes. Variants in intron 13 of the ELMO1 gene appear to confer risk for diabetic nephropathy in AA. FAU - Leak, T S AU - Leak TS AD - Center for Human Genomics, Wake Forest University School of Medicine, Winston-Salem, NC, USA. FAU - Perlegas, P S AU - Perlegas PS FAU - Smith, S G AU - Smith SG FAU - Keene, K L AU - Keene KL FAU - Hicks, P J AU - Hicks PJ FAU - Langefeld, C D AU - Langefeld CD FAU - Mychaleckyj, J C AU - Mychaleckyj JC FAU - Rich, S S AU - Rich SS FAU - Kirk, J K AU - Kirk JK FAU - Freedman, B I AU - Freedman BI FAU - Bowden, D W AU - Bowden DW FAU - Sale, M M AU - Sale MM LA - eng GR - M01 RR007122-150269/RR/NCRR NIH HHS/United States GR - R01 DK066358-03/DK/NIDDK NIH HHS/United States GR - DK 066358/DK/NIDDK NIH HHS/United States GR - R01 DK066358-02/DK/NIDDK NIH HHS/United States GR - R01 DK066358-02S1/DK/NIDDK NIH HHS/United States GR - DK 072550/DK/NIDDK NIH HHS/United States GR - R01 DK070941/DK/NIDDK NIH HHS/United States GR - F31 DK072550/DK/NIDDK NIH HHS/United States GR - R01 DK066358-01/DK/NIDDK NIH HHS/United States GR - R01 DK066358/DK/NIDDK NIH HHS/United States GR - M01 RR007122/RR/NCRR NIH HHS/United States GR - M01 RR 07122/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20090123 PL - England TA - Ann Hum Genet JT - Annals of human genetics JID - 0416661 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (ELMO1 protein, human) SB - IM MH - Adaptor Proteins, Signal Transducing/*genetics MH - Black or African American/*genetics MH - Aged MH - Diabetes Mellitus, Type 2/complications MH - Diabetic Nephropathies/*ethnology/*genetics MH - Female MH - *Genetic Predisposition to Disease MH - Humans MH - Introns MH - Male MH - Middle Aged MH - Polymorphism, Single Nucleotide PMC - PMC2778056 MID - NIHMS85350 EDAT- 2009/02/03 09:00 MHDA- 2009/03/19 09:00 PMCR- 2010/03/01 CRDT- 2009/02/03 09:00 PHST- 2009/02/03 09:00 [entrez] PHST- 2009/02/03 09:00 [pubmed] PHST- 2009/03/19 09:00 [medline] PHST- 2010/03/01 00:00 [pmc-release] AID - AHG498 [pii] AID - 10.1111/j.1469-1809.2008.00498.x [doi] PST - ppublish SO - Ann Hum Genet. 2009 Mar;73(2):152-9. doi: 10.1111/j.1469-1809.2008.00498.x. Epub 2009 Jan 23.